当前位置: 首页 > 期刊 > 《新医学》 > 201911
编号:13527921
呼吸湿化治疗仪对慢性心力衰竭伴低氧血症患者血气分析指标及D-二聚体水平的影响(4)
http://www.100md.com 2019年11月1日 《新医学》 201911
     [6] 徐晓飞. 无创呼吸机治疗急性心力衰竭的疗效观察. 中华全科医学, 2016, 14(10):1669-1670.

    [7] Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and outcomes of noninvasive ventilation for acute respiratory failure in different age groups. Respir Care,2016,61(1):36-43.

    [8] 李海泉, 赵杰, 贾晓民,张衍民,马雷,徐永红,杜永亮,徐俊马. 呼吸湿化治疗仪在慢阻肺合并CAP患者中的应用效果分析. 临床肺科杂志,2018,23(2):260-262.

    [9] 彭俊,陈羽青,叶健鸿,杨雪莹,彭书崚,左志义. 经鼻高流量吸氧对预充氧及安全窒息时限的影响. 中山大学学报(医学科学版), 2018, 39(2):263-268.

    [10] 吕喆, 李峰, 王耀辉. 呼吸湿化治疗仪辅助治疗老年卒中相关性肺炎60例. 武警医学, 2018, 29(3):293-294.

    [11] Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, Navalesi P, Members of the Steering Committee, Antonelli M, Brozek J, Conti G, Ferrer M, Guntupalli K, Jaber S, Keenan S, Mancebo J, Mehta S, Raoof S, Members of the Task Force. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J,2017,50(2): 1602426.

    [12] 刘书雁, 韦伶郁, 陈伟栋, 徐嘉. 经鼻高流量鼻导管湿化氧疗对急性呼吸衰竭的临床疗效分析. 新医学,2019,50(1):22-25.

    [13] D'Alessio A, Marchetti M, Tartari CJ, Russo L, Cecchini S, Lambregts KWFM, di Mauro D, Falanga A. Long term low molecular weight heparin anticoagulant therapy modulates thrombin generation and d-dimer in patients with cancer and venous thromboembolism. Cancer Invest,2017,35(7):490-499.

    [14] 符春苗. 血漿D-二聚体和N末端B型利钠肽原水平对超高龄心力衰竭患者心功能及预后的评估价值. 实用心脑肺血管病杂志, 2016, 24(1):127-128.

    [15] Garde A, S?rnmo L, Laguna P, Jané R, Benito S, Bayés-Genís A, Giraldo BF. Assessment of respiratory flow cycle morphology in patients with chronic heart failure. Med Biol Eng Comput,2017,55(2):245-255.

    (收稿日期:2019-03-26)

    (本文编辑:林燕薇), http://www.100md.com(杜璐玲?陈建永?陈楚芬)
上一页1 2 3 4